Psychedelic Science 2023

Be Part of

        the Breakthrough

Presented by

Improving study design in trials using psychedelic-assisted therapies


Improving study design in trials using psychedelic-assisted therapies

Psychedelic research has gained the attention of the scientific community, popular media, and the public at large. With the expansion of the field, people seeking to participate in such studies may bring a set of expectations that can undermine the validity of trial outcomes. Increased methodological rigor is needed to address this, as well as some of the inherent challenges to psychedelic research, such as difficulty with blinding. In the effort to control bias, there is the risk of losing the impact of subjectivity in psychedelic clinical trials. Some studies seek to isolate the "drug effect" from the phenomenological experience of participants. How do we navigate this tension?

Share: Improving study design in trials using psychedelic-assisted therapies


Already Registered?

If you already registered for the in-person portion of the Psychedelic Science 2023 conference, get immediate access to PS2023: The Virtual Trip by logging in with the email address you used when signing up for the conference. We’ll email you a login link—no password necessary!

Need to Register?

If you are not yet registered for Psychedelic Science 2023, you can sign up for PS2023: The Virtual Trip access by creating an account.

Report an Error

The PS2023: The Virtual Trip team has worked hard to create session captions, transcripts, and web pages as accurately as possible, but we know that some errors may have made it past our review process. Let us know what needs to be fixed! Please provide the session name and/or page URL where you found the error, the time the error occurs (if in a video), and the correct information we should use to fix the error. We appreciate your help in making PS2023: The Virtual Trip even better!

This field is for validation purposes and should be left unchanged.